Three hospital groups announced their plan to sue the Centers for Medicare & Medicaid Services over the agency’s recent decision to drastically reduce outpatient drug payments under the 340B drug program.
The Institute for Safe Medication Practices recently warned consumers about the safety of two newly approved drugs following postmarket adverse events.
A team of pharmacists devised a standardized approach to ensure only patients who need chemotherapy receive it, and to minimize inappropriate use.
In a new study, researchers reported that the quadrivalent HPV vaccine led to a reduction in juvenile-onset recurrent respiratory papillomatosis in children in Australia.
The FDA recently approved brentuximab vedotin (Adcetris) to treat adults with primary cutaneous anaplastic large cell lymphoma or mycosis fungoides.
Pharmacy Practice News Report is brought to MedPage Today readers by our friends Pharmacy Practice News, a McMahon Group title. Registration (free) may be required for some content.